Associative Memory in Autism Spectrum Disorder (MEM-TA)
Primary Purpose
Autistic Disorder
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Electroencephalography
Neuropsychological assessment
Sponsored by
About this trial
This is an interventional basic science trial for Autistic Disorder focused on measuring Autism Spectrum Disorder, Development, Memory, ERD
Eligibility Criteria
Inclusion Criteria:
- Right handed children from 10 to 18 years old
- Informed consent signed by the legal representative and adolescent himself.
Medical Examinations, psychopathology, and cognitive examination in accordance with inclusion and exclusion criteria specific to each population:
People with ASD:
- Participants with ASD without mental retardation with a diagnosis in reference to the DSM V criteria
- Controls : Participants without ASD
Main exclusion criteria:
- mental retardation,
- schizophrenia,
- ADHD,
- head injury with lost of consciousness
Sites / Locations
- Caen University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Patients
Control
Arm Description
Electroencephalography and neuropsychological tests in children with autism
Electroencephalography and neuropsychological tests in children without autism
Outcomes
Primary Outcome Measures
Index of discrimination obtained with the task of associative memory
Secondary Outcome Measures
Full Information
NCT ID
NCT02265094
First Posted
October 9, 2014
Last Updated
February 19, 2018
Sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Amiens University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02265094
Brief Title
Associative Memory in Autism Spectrum Disorder
Acronym
MEM-TA
Official Title
Associative Memory in ASD Without Mental Retardation : Study in EEG and Neuropsychology
Study Type
Interventional
2. Study Status
Record Verification Date
February 2018
Overall Recruitment Status
Unknown status
Study Start Date
December 22, 2015 (Actual)
Primary Completion Date
December 2018 (Anticipated)
Study Completion Date
December 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Amiens University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to investigate the neural substrates of associative memory in Autism Spectrum Disorder using both behavioural and EEG assessments.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autistic Disorder
Keywords
Autism Spectrum Disorder, Development, Memory, ERD
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Patients
Arm Type
Experimental
Arm Description
Electroencephalography and neuropsychological tests in children with autism
Arm Title
Control
Arm Type
Experimental
Arm Description
Electroencephalography and neuropsychological tests in children without autism
Intervention Type
Other
Intervention Name(s)
Electroencephalography
Intervention Description
EEG recordings during memory tests
Intervention Type
Behavioral
Intervention Name(s)
Neuropsychological assessment
Intervention Description
patterns of eye gaze during cognitive tests
Primary Outcome Measure Information:
Title
Index of discrimination obtained with the task of associative memory
Time Frame
4 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Right handed children from 10 to 18 years old
Informed consent signed by the legal representative and adolescent himself.
Medical Examinations, psychopathology, and cognitive examination in accordance with inclusion and exclusion criteria specific to each population:
People with ASD:
Participants with ASD without mental retardation with a diagnosis in reference to the DSM V criteria
Controls : Participants without ASD
Main exclusion criteria:
mental retardation,
schizophrenia,
ADHD,
head injury with lost of consciousness
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bérengère GUILLERY-GIRARD, PhD
Phone
0231064347
Email
berengere.guillery@unicaen.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Marc BALEYTE, MD
Organizational Affiliation
University Hospital, Caen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Caen University Hospital
City
Caen
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Baleyte Jean Marc
12. IPD Sharing Statement
Learn more about this trial
Associative Memory in Autism Spectrum Disorder
We'll reach out to this number within 24 hrs